September 13, 2017 Princeton, New Jersey:Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and an end-to-end provider of transformative solutions across the spectrum of Clinical, Regulatory and Safety in Life Sciences announced that it has been recognized as a ‘Leader’ in the IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment (Doc # US42595616, June 2017).
Leadership in this study is based on the breadth of drug safety services, delivery, and experience targeted toward an increasingly global and diversified Life Sciences market with a view toward both today’s evolving needs and looking forward over the next three to five years. Navitas Life Sciences was one of eight vendors selected to participate in this study based on the IDC MarketScape’s stringent research and due diligence process.
Mr. Ram Yeleswarapu, President, Navitas Life Sciences said, “We are proud that our competitive strengths of deep domain expertise, embedded IPs in solutions & services, thought leadership in Life Sciences and tradition of delivery excellence have been recognized in this prestigious publication.” He added, “The Life Sciences industry is being driven by the need for safer, more effective and affordable medicines for the global population, with a series of regulations aimed at this end. With our proven capabilities, we are well poised to capitalize on the opportunities before us.”
Author of the report Mr. Alan S. Louie, Ph .D. said, “The Life Sciences industry is witnessing a growing demand for drug safety (DS) services as companies are increasingly beginning to rely on validated, industry specific service providers to deliver desired outcomes. Players like Navitas Life Sciences can be considered among those service providers who are in a position to deliver efficient and transformative drug safety services.”
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
About Navitas Life Sciences
Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions, works as a strategic partner for large and mid-sized Life Sciences organizations to address critical challenges and achieve desired outcomes. Navitas’ technology-led Life Sciences services are augmented with the full-service CRO with Clinical & BA/BE capabilities, and Life Sciences data analytics expertise of legacy brands Ecron Acunova and Intelent to deliver flexible, scalable and innovative solutions for its global clients.
As a strategic partner, Navitas leverages industry insights and domain expertise to develop and implement consulting, technology and functional services across the spectrum of Clinical, Regulatory and Safety, to innovative and create value to address the needs of the industry uniquely. Navitas Life Sciences brings together the proven expertise of its legacy brands to create a positive business impact and drive better outcomes for clients. For more information, visit www.navitaslifesciences.com.
About TAKE Solutions
TAKE Solutions is a globally recognized knowledge intensive player, delivering comprehensive and niche solutions in Life Sciences (LS). TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient Clinical, Regulatory, Safety outcomes for global clients. TAKE encompasses specialized capabilities under its Life Sciences business Navitas, whose technology-led Life Sciences services across Clinical, Regulatory and Safety are augmented by full-service CRO with Clinical & BA/BE capabilities and Big Data analytics expertise of its legacy brands Ecron Acunova and Intelent. Navitas Life Sciences delivers flexible and scalable solutions by seamlessly combining best-in-class processes, meaningful and unique industry insight, innovative technology, exacting analytics and a customer-centric culture.
TAKE’s significant recognitions include a patent win from the United State‘Leader’ in the IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 vendor assessment, recognition as the ‘Dream Employer of the Year’ at the World HRD Congress, the title of ‘Most Admired Brand –IT’ from the Asian Customer Engagement Forum and a Special Commendation for excellence in Corporate Governance from the Golden Peacock Awards. With its global headquarters in Chennai, India, TAKE has a proven track record of delivering world-class solutions to more than 150 customers worldwide, including 9 of the top 10 global Pharma companies. For more information, please visit www.takesolutions.com.